The National Comprehensive Cancer Network (NCCN) guidelines for genetic assessment in hereditary breast cancer (version 3.2019) recommends genetic evaluation of ATM, CDH1, CHEK2, NBN, NF1, and PALB2 in addition to BRCA1/2 genes. The gene discussed is PALB2; the disease is breast carcinoma.